I[NTRODUCTION]{.smallcaps} {#sec1-1}
==========================

Atopic dermatitis (AD), also known as atopic eczema, is a chronic inflammatory skin disease characterized by eczematous dermatitis and itching.\[[@ref1][@ref2][@ref3]\] The prevalence of childhood AD ranged from 15% to 30% while adult AD from 2% to 10% in industrialized countries.\[[@ref4]\] AD is often associated with other allergic conditions. Patients with AD often have personal and/or family history of other atopic diseases such as asthma, allergic rhinitis, and allergic conjunctivitis.\[[@ref5][@ref6][@ref7]\] The clinical manifestations of AD are heterogeneous. Three stages are proposed including infantile AD, childhood AD, and adolescent/adult AD. The clinical features vary with stages. Elevation in total serum IgE level, eosinophilia, and allergen-specific IgE are main laboratory abnormalities of AD. Although the etiology and pathogenesis of AD remain unknown, mounting evidences have suggested that genetic predisposition such as defect of filaggrin synthesis\[[@ref8]\] and environmental factors such as allergen exposure\[[@ref9]\] contribute to the formation of AD. Studies have shown that dysfunction of skin barrier\[[@ref10]\] and Th2 predominant immunity\[[@ref11]\] play vital roles in the pathogenesis of AD.

In China, the symmetrical eczematous dermatitis is often diagnosed as eczema. We have performed a survey in 3016 Chinese dermatologists about the diagnosis in patients with symmetrical eczematous dermatitis. About half dermatologists claimed that more than 90% of these patients were diagnosed as eczema and \<10% was diagnosed as AD (unpublished data), indicating an over-diagnosis of eczema and under-diagnosis of AD in China.

Several diagnostic criteria for AD have been proposed, including Hanifin and Rajka criteria,\[[@ref12]\] Williams criteria,\[[@ref13][@ref14][@ref15]\] and Japanese Dermatological Association (JDA) criteria.\[[@ref16]\] Hanifin and Rajka criteria include 4 major features and 23 minor features and the diagnosis of AD requires 3 major features and 3 minor features, which are rather complicated. Williams criteria include six features. JDA criteria are composed of only 3 clinical features. The differences in diagnosis criteria may explain the variability of the prevalence of AD reported in different studies. In clinical practice, we found that Hanifin and Rajka criteria and Williams criteria were not easy for clinical use while some suspected the specificity of JDA criteria because they contained only 3 clinical features.

Although AD occurs both in children and adults, the studies in childhood AD are much more than that in adult AD. In China, there has been no large-scale study on adult/adolescent AD. We performed a hospital-based study to analyze the clinical features of adult/adolescent AD and tried to propose Chinese diagnostic criteria for these patients based on the clinical and laboratory findings.

M[ETHODS]{.smallcaps} {#sec1-2}
=====================

Patients {#sec2-1}
--------

This study was performed in 42 dermatological centers. Patients older than 12 years with symmetrical eczematous dermatitis for more than 2 months were included in this study regardless of the clinical diagnosis (eczema or AD). The informed consents were obtained from each patient.

Questionnaires and dermatological examinations {#sec2-2}
----------------------------------------------

All investigators were trained for completing the questionnaire and for dermatological examinations. The study was performed from September 2013 to September 2014. The standardized questionnaires were completed by patients and investigators. The investigators also performed dermatological examination for characterization of the skin manifestations. In some patients, the complete blood count, total serum IgE level, and allergen-specific IgE were measured.

Data entry and statistical analysis {#sec2-3}
-----------------------------------

All the valid data were input by EpiData 3.1 software (The EpiData Association, <http://www.epidata.dk/>, Denmark) and analyzed by Statistical Package for Social Science 17.0 software (SPSS Inc., Chicago, IL, USA). Counting and ranked data were performed with number or constituent ratio (*n* or %), and measurement data were performed with mean ± standard deviation (SD). Comparison of counting data were analyzed using Pearson Chi-square test, comparison of ranked data were analyzed using Wilcoxon test, and comparison of measurement data were analyzed using independent sample *t*-test. Pearson and Spearman correlation index were applied to describe the correlation between ranked data and measurement data. A *P* \< 0.05 was considered significant.

R[ESULTS]{.smallcaps} {#sec1-3}
=====================

Demographical features of the patients {#sec2-4}
--------------------------------------

A total of 2662 valid questionnaires were collected (1369 male and 1293 female). The mean age of the patients was 40.6 ± 18.9 years old (12.1--93.0 years old). Among them, 88.0% patients were older than 18 years old; 84.1% of patients were from urban areas while 15.9% patients were from rural areas \[[Table 1](#T1){ref-type="table"}\].

###### 

Demographic characteristics of the 2662 patients

  Variables                              Results
  -------------------------------------- --------------
  Gender, *n* (%)                        
   Male                                  1369 (51.4)
   Female                                1293 (48.6)
  Age                                    
   Mean age (years, Mean ± SD)           40.6 ± 18.9
   12≤ age \<18 years old, *n* (%)       320 (12.0)
   ≥18 years old, *n* (%)                2342 (88.0)
  Height (cm, Mean ± SD)                 166.5 ± 23.4
  Weight (kg, Mean ± SD)                 61.6 ± 13.6
  Body mass index (kg/m^2^, Mean ± SD)   22.5 ± 3.9
  Residence, *n* (%)                     
   Urban area                            2240 (84.1)
   Rural area                            422 (15.9)

Clinical and laboratory features {#sec2-5}
--------------------------------

Of all the patients, 600 (22.5%) had the disease before 12 years old, while 2062 (77.5%) patients had the disease after 12 years old. Approximately one-third (34.5%) patients were diagnosed as AD and 65.5% were diagnosed as eczema by investigators. The clinical features of these patients are summarized in [Table 2](#T2){ref-type="table"}. The laboratory findings are summarized in [Table 3](#T3){ref-type="table"}.

###### 

Clinical manifestations of the 2662 patients with symmetrical dermatitis/eczema

  Clinical manifestations                                 *n* (%)
  ------------------------------------------------------- -------------
  Pruritus                                                2628 (98.7)
  Chronic course (\>6 months)                             2139 (80.4)
  Disease influenced by environmental/emotional factors   1904 (71.5)
  Xerosis                                                 1786 (67.1)
  Itching upon sweating                                   1395 (52.4)
  Personal or family history of atopic diseases           1144 (43.0)
   Personal history of atopic diseases                    725 (27.2)
   Family history of atopic diseases                      801 (30.1)
    First-degree relative                                 694 (26.1)
    Second-degree relative                                231 (8.7)
    Third-degree relative                                 108 (4.1)
  Flexural dermatitis                                     1123 (42.2)
  Visible flexural dermatitis                             961 (36.1)
  Food intolerance                                        900 (33.8)
  Facial pallor/facial erythema                           847 (31.8)
  Intolerance to wool                                     695 (26.1)
  Urticaria/angioedema                                    652 (24.5)
  Scalp eczema/pityriasis                                 611 (23.0)
  Eczema/AD before 12 years old                           600 (22.5)
  Periauricular fissuring/eczema                          542 (20.4)
  Hand and/or foot dermatitis                             535 (20.1)
  Ichthyosis/palmar hyperlinearity/keratosis pilaris      521 (19.6)
  White dermographism                                     506 (19.0)
  Perifollicular accentuation                             436 (16.4)
  Eyelid eczema                                           436 (16.4)
  Nummular eczema                                         413 (15.5)
  Pompholyx of hand/foot                                  405 (15.2)
  Eczema/AD history before 2 years old                    387 (14.5)
  Liable to skin infections                               387 (14.5)
  Anterior neck folds                                     364 (13.7)
  Cheilitis                                               341 (12.8)
  Perineum eczema                                         313 (11.8)
  Orbital darkening                                       262 (9.8)
  Pityriasis alba                                         215 (8.1)
  Breast eczema                                           177 (6.6)
  Recurrent conjunctivitis                                146 (5.5)
  Dennie--Morgan infraorbital fold                        145 (5.4)
  Anterior subcapsular cataracts                          73 (2.7)
  Keratoconus                                             31 (1.2)

AD: Atopic dermatitis.

###### 

Laboratory findings of the 2662 patients with symmetrical dermatitis/eczema

  Laboratory findings                                                                  *n*/*N* (%)
  ------------------------------------------------------------------------------------ ------------------
  Elevated total serum IgE                                                             1303/2496 (52.2)
  Eosinophilia                                                                         740/2327 (31.8)
  Positive allergen-specific IgE                                                       355/1153 (30.8)
  Elevated total serum IgE and/or eosinophilia and/or positive allergen-specific IgE   1548/2662 (58.2)

Propose of Chinese criteria for adult/adolescent atopic dermatitis {#sec2-6}
------------------------------------------------------------------

Based on the clinical and laboratory findings in these patients, we proposed a set of criteria for adult/adolescent AD \[[Table 4](#T4){ref-type="table"}\].

###### 

Chinese criteria for adult/adolescent AD

  -------------------------------------------------------------------------------------------
  Must have
   Symmetrical eczema (dermatitis) for more than 6 months\*
  Plus one or more of the following
   Personal^†^ and/or family history^‡^ of atopic diseases
   Elevated total serum IgE level and/or positive allergen-specific IgE and/or eosinophilia
  -------------------------------------------------------------------------------------------

\*More than 6 months: Persistent or recurrent eczema/dermatitis for more than 6 months; ^†^Personal history of atopic diseases: Allergic rhinitis and/or allergic asthma and/or allergic conjunctivitis; ^‡^Family history of atopic diseases: Eczema/AD and/or allergic rhinitis and/or allergic asthma and/or allergic conjunctivitis in first-, second- or third-degree relatives. AD: Atopic dermatitis.

Sensitivity of Chinese criteria for diagnosis of adult/adolescent atopic dermatitis {#sec2-7}
-----------------------------------------------------------------------------------

By our criteria, 60.3% of these patients were diagnosed as AD while only 48.2% were diagnosed as AD by Hanifin and Rajka criteria and 32.7% by Williams criteria, suggesting a good sensitivity of our criteria in adult/adolescent AD patients although our criteria were less sensitive than JDA criteria (79.4%) \[[Table 5](#T5){ref-type="table"}\]. The clinical features of AD and non-AD patients are summarized in [Table 6](#T6){ref-type="table"}.

###### 

Comparison of sensitivity of different criteria for diagnosis of adult/adolescent AD

  Criteria                     AD/total    Percentage
  ---------------------------- ----------- ------------
  Our criteria                 1605/2662   60.3
  Hanifin and Rajka criteria   1184/2455   48.2
  Williams criteria            866/2648    32.7
  JDA criteria                 2110/2656   79.4

AD: Atopic dermatitis; JDA: Japanese Dermatological Association.

###### 

Clinical features of adult/adolescent AD

  Clinical features                                       AD (*n* = 1605), *n* (%)   Non-AD (*n* = 1057), *n* (%)   *χ*^2^    *P*
  ------------------------------------------------------- -------------------------- ------------------------------ --------- -------
  Pruritus                                                1582 (98.6)                1046 (99.0)                    0.778     0.378
  Xerosis                                                 1190 (74.1)                596 (56.5)                     89.332    0.000
  Disease influenced by environmental/emotional factors   1186 (73.9)                718 (68.1)                     10.834    0.001
  Personal or family history of atopic diseases           986 (61.4)                 158 (14.9)                     561.936   0.000
  Itching upon sweating                                   898 (56.0)                 497 (47.2)                     19.739    0.000
  Flexural dermatitis                                     833 (52.0)                 290 (27.6)                     154.481   0.000
  Visible flexural dermatitis                             686 (42.8)                 275 (26.2)                     75.785    0.000
  Food intolerance                                        613 (38.2)                 287 (27.2)                     34.527    0.000
  Facial pallor/facial erythema                           569 (35.5)                 278 (26.4)                     24.142    0.000
  Intolerance to wool                                     484 (30.2)                 211 (20.0)                     34.281    0.000
  Eczema/AD before 12 years old                           473 (29.5)                 127 (12.1)                     110.266   0.000
  Scalp eczema/pityriasis                                 461 (28.8)                 150 (14.2)                     75.579    0.000
  Urticaria/angioedema                                    430 (26.8)                 222 (21.1)                     11.462    0.001
  Periauricular fissuring/eczema                          413 (25.8)                 129 (12.3)                     71.453    0.000
  Hand and/or foot dermatitis                             396 (24.7)                 139 (13.2)                     52.327    0.000
  Ichthyosis/palmar hyperlinearity/keratosis pilaris      374 (23.3)                 147 (13.9)                     35.434    0.000
  Eyelid eczema                                           333 (20.8)                 103 (9.8)                      55.963    0.000
  Eczema/AD history before 2 years old                    323 (20.2)                 64 (6.1)                       101.396   0.000
  Perifollicular accentuation                             313 (19.5)                 123 (11.7)                     28.466    0.000
  White dermographism                                     305 (19.0)                 201 (19.1)                     0.001     0.975
  Nummular eczema                                         295 (18.4)                 118 (11.2)                     25.296    0.000
  Pompholyx of hand/foot                                  275 (17.2)                 130 (12.3)                     11.376    0.001
  Liable to skin infections                               270 (16.8)                 117 (11.1)                     16.648    0.000
  Anterior neck folds                                     267 (16.7)                 97 (9.2)                       30.138    0.000
  Cheilitis                                               240 (15.0)                 101 (9.6)                      16.462    0.000
  Perineum eczema                                         230 (14.3)                 83 (7.9)                       25.558    0.000
  Orbital darkening                                       182 (11.4)                 80 (7.6)                       10.262    0.001
  Pityriasis alba                                         152 (9.5)                  63 (6.0)                       10.475    0.001
  Breast eczema                                           126 (7.9)                  51 (4.8)                       9.288     0.002
  Recurrent conjunctivitis                                117 (7.3)                  29 (2.7)                       25.391    0.000
  Dennie--Morgan infraorbital fold                        97 (6.1)                   48 (4.5)                       2.799     0.094
  Anterior subcapsular cataracts                          54 (3.4)                   19 (1.8)                       5.848     0.016
  Keratoconus                                             21 (1.3)                   10 (0.9)                       0.731     0.393

AD: Atopic dermatitis.

D[ISCUSSION]{.smallcaps} {#sec1-4}
========================

Eczema and dermatitis are the most common skin diseases. AD is regarded as a special form of eczema with characteristic clinical manifestations and laboratory findings. Hence, AD is also called atopic eczema. In nearly all textbooks of dermatology, eczema and AD were described as two skin diseases.\[[@ref17]\] In China, the diagnosis of eczema was much more common than AD.

According to the definition, AD is characterized by dermatitis with personal and/or family history of atopic diseases, increased serum IgE level and/or eosinophilia. Some regarded that AD is a syndrome rather than a simple skin disease. Several diagnostic criteria for AD have been proposed. Hanifin and Rajka criteria were proposed in 1980 and were widely used.\[[@ref12][@ref18]\] Brenninkmeijer *et al*.\[[@ref19]\] reported that the sensitivity of Hanifin and Rajka criteria was 87.9--96.0%, and the specificity was 77.6--93.8%. However, Hanifin and Rajka criteria had 27 clinical features (4 major features and 23 minor features), which were rather complicated for clinical use. William\'s criteria were relatively simple with 6 items. However, the "flexural dermatitis" and "onset before 2 years old" would exclude those who did not have flexural dermatitis and those who had the disease after 2 years old. JDA criteria were much simpler with only three clinical features. However, this may lower the specificity because the three features were just from four major features of Hanifin and Rajka criteria.

According to our findings in 2662 patients, we proposed three features as the criteria for adult/adolescent AD: (1) eczema for more than 6 months; (2) personal and/or family history of atopic diseases; (3) elevated total serum IgE level and/or positive allergen-specific IgE and/or eosinophilia. Because it has only 3 features, it is much easier for clinical use although it requires some laboratory tests. The pruritus is not included in our criteria because it is not specific for AD. Many other skin diseases also have pruritus. Similarly, "dry skin" is also not included in our criteria because it is rather subjective.

"Eczema for more than 6 months," "personal and/or family history of atopic diseases" and "elevated total serum IgE level and/or positive allergen-specific IgE and/or eosinophilia" are much specific for AD. As is well-known, the concept of atopy has been widely accepted for a long time,\[[@ref17][@ref20]\] focusing on the familial hypersensitivity of skin/mucosa and increased IgE level.\[[@ref2]\] The definition of atopy has been revised in recent years as follows: Atopy is a personal or familial tendency to produce IgE antibodies in response to low doses of allergens, and to develop typical symptoms such as asthma, rhinoconjunctivitis, or eczema/dermatitis.\[[@ref5]\] From this perspective, the three features we have chosen meet the meaning of atopy properly.

"Eczema for more than 6 months" represents to the chronic course of AD and has been widely accepted. "Chronic or chronically relapsing dermatitis" was required in Hanifin and Rajka criteria proposed in 1980, but there was no explanation of specific course for "chronic." Later in 1994, the JDA developed diagnostic criteria for AD, which was partly revised in 2008, defined the "chronic or chronically relapsing course" as "more than 6 months in childhood, adolescent, and adulthood."\[[@ref16]\] At the same time, the International Study of Asthma and Allergies in Childhood proposed a widely-used questionnaire for AD diagnosis in 1995, which also adopted the chronic course as 6 months.\[[@ref21]\] Therefore, we consider that "eczema for more than 6 months" is necessary for the diagnosis of AD.

"Personal and/or family history of atopic diseases" stands for the importance of genetic factor and syndrome nature of the disease. As we all know, this feature has been accepted in AD diagnosis for many years by lots of criteria, such as the Hanifin and Rajka criteria and Williams criteria. Meanwhile, a revised Hanifin and Rajka criteria proposed by the American Academy of Dermatology, also chose "personal and/or family history" as one of the important features of AD.\[[@ref22][@ref23]\] However, Hanifin and Rajka criteria and the revised version did not mention the the degree of relatives for family history, and Williams criteria just suggested a history of atopic disease in the first-degree relative in children under 4 years old. However, in our patients, 8.7% of the second-degree relatives and 4.1% third-degree relatives had atopic diseases \[[Table 2](#T2){ref-type="table"}\], so the family history in our criteria included not only the first-degree relatives but also the second-, and third-degree relatives.

Elevation in total serum IgE level and/or positive specific IgE and/or eosinophilia are all the characteristics of "atopy." The elevated total serum IgE is one of the diagnostic features in Hanifin and Rajka criteria. In our patients, 52.2% had increased serum IgE level. In millennium criteria proposed by Bos *et al*.,\[[@ref24]\] the presence of allergen-specific IgE was a mandatory criterion.\[[@ref25]\] In our patients, 30.8% had specific IgE to at least one allergen. Eosinophilia is another characteristic of AD and was found in 31.8% of our patients. Because eosinophils are very sensitive to systemic corticosteroid treatment, so if eosinophil is normal, careful history taking, especially about the systemic use of steroid is necessary.

It has been widely accepted that AD is a systemic disease, and the skin manifestations are only a part of the disorder.\[[@ref26][@ref27]\] The European Academy of Allergology and Clinical Immunology (EAACI) task force proposed the term "atopic eczema/dermatitis syndrome" instead of the current "atopic eczema/dermatitis,"\[[@ref5]\] underlining the fact that "AD" is a syndrome with certain clinical characteristics in common.\[[@ref28]\] In keeping with the EAACI nomenclature, we agree that AD is a syndrome involving both skin and other organs such as respiratory tract, and is usually associated with elevation of total serum IgE and eosinophils. On the other hand, eczema is often a descriptive diagnosis, often referring to a broad range of conditions that begin as spongiotic dermatitis and may progress to a lichenified stage.\[[@ref17]\] Moreover, AD is a chronic or chronically-relapsing disease while the eczema could be acute, subacute, or chronic.

It has been reported that approximately 45% AD patients had the disease within the first 6 months of life, 60% had AD during the 1^st^ year and 85% before 5 years of age.\[[@ref4]\] Ingordo *et al*.\[[@ref29]\] reported that 8.8% of eczema were adult-onset AD. Ozkaya\[[@ref30]\] reported that adult-onset AD account for 16.8% of total AD patients. While in our study, 77.5% patients had eczema or AD after 12 years old, indicating late-onset eczema/AD is quite common.

We compared the sensitivity between our criteria and other criteria. Of all 2662 patients, 60.3% satisfied our criteria, 48.2% satisfied Hanifin and Rajka criteria, 32.7% satisfied Williams, suggesting that our criteria have higher sensitivity in adult/adolescent AD patients. Although our criteria were less sensitive than JDA criteria (79.4%), they might increase the specificity with inclusion of personal/familial atopy history and laboratory evidence for atopy. With regard to the fact that the current AD clinical diagnostic rate was only 34.5%, our criteria could increase the diagnosis of AD by 25.8% in these patients.

Our study was a hospital-based retrospective clinical study, including only eczema and AD patients, and the population were restricted to adolescents and adults. Therefore, it is only for adult and adolescent. This is the limitation of our criteria. Furthermore, our criteria need more large-scale study for verification.

While our criteria are helpful for the diagnosis of adult/adolescent AD, it is necessary to differentiate some diseases that might satisfy this set of criteria such as hyper-eosinophilic syndrome, Wiscott--Aldrich syndrome, Netherton syndrome, hyper-IgE syndrome, Sezary disease and other diseases.
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